Document is current
Any future updates will be listed below
-
Authors
Morales, Erin
Olson, Michael
Iglesias, Fiorella
Dahiya, Saurabh
Luetkens, Tim
Atanackovic, Djordje
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02657005 at ClinicalTrials.govnct03600649 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma
https://doi.org/10.1200/jco.24.00020
nct01858168 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
nct03495921 at ClinicalTrials.govDocuments that mention this clinical trial
Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway
https://doi.org/10.1016/j.ejca.2015.09.009
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
nct02306161 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
nct00516295 at ClinicalTrials.govDocuments that mention this clinical trial
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group
https://doi.org/10.1200/jco.22.01815
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
nct02659020 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
nct01748721 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
nct03356782 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
nct03618381 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
Immunotherapy for sarcomas: new frontiers and unveiled opportunities
https://doi.org/10.1136/jitc-2020-001580
An update on emerging drugs in osteosarcoma: towards tailored therapies?
https://doi.org/10.1080/14728214.2019.1654455
nct02194374 at ClinicalTrials.govDocuments that mention this clinical trial
Precision targeting of rhabdomyosarcoma by combining primary CAR NK cells and radiotherapy
https://doi.org/10.1136/jitc-2024-011330
Cell therapy in sarcoma: current landscape and future directions
https://doi.org/10.1136/jitc-2025-013396
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
Immunotherapy for sarcomas: new frontiers and unveiled opportunities
https://doi.org/10.1136/jitc-2020-001580
An update on emerging drugs in osteosarcoma: towards tailored therapies?
https://doi.org/10.1080/14728214.2019.1654455
nct02706392 at ClinicalTrials.govDocuments that mention this clinical trial
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
Documents that mention this clinical trial
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
https://doi.org/10.1136/jitc-2020-000676
Role of immunotherapy in Ewing sarcoma
https://doi.org/10.1136/jitc-2020-000653
Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead
https://doi.org/10.1136/jitc-2021-002723
- License Information
